The estimated Net Worth of Dean Burstein Melissa Dean ... is at least $1.76 Milhão dollars as of 27 April 2020. Dean Dean owns over 130,800 units of Catheter Precision stock worth over $1,618,873 and over the last 4 years Dean sold RMED stock worth over $137,340.
Dean has made over 1 trades of the Catheter Precision stock since 2020, according to the Form 4 filled with the SEC. Most recently Dean sold 130,800 units of RMED stock worth $137,340 on 27 April 2020.
The largest trade Dean's ever made was selling 130,800 units of Catheter Precision stock on 27 April 2020 worth over $137,340. On average, Dean trades about 130,800 units every 0 days since 2020. As of 27 April 2020 Dean still owns at least 2,743,852 units of Catheter Precision stock.
You can see the complete history of Dean Dean stock trades at the bottom of the page.
Over the last 6 years, insiders at Catheter Precision have traded over $709,539 worth of Catheter Precision stock and bought 199,373 units worth $197,741 . The most active insiders traders include Jeffrey J Kraws, Jonathan Will Mc Guire, eDean Burstein Melissa Dean .... On average, Catheter Precision executives and independent directors trade stock every 34 days with the average trade being worth of $12,983. The most recent stock trade was executed by Andrew C. Jackson on 20 November 2021, trading 2,684 units of RMED stock currently worth $7,032.
advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of
Catheter Precision executives and other stock owners filed with the SEC include: